• How Access to Treatments Impacts Trials: From Protocol Development, to Country and Site Selection with Kasia Harris

  • Sep 17 2024
  • Length: 33 mins
  • Podcast

How Access to Treatments Impacts Trials: From Protocol Development, to Country and Site Selection with Kasia Harris

  • Summary


  • Meet Kasia Harris - an expert in clinical trial feasibility and planning with experience in both CRO and Pharma. bringing valuable insights into the complexities of global healthcare systems. In this episode, Kasia and Maya delve into the critical role of understanding local standard of care in clinical trial success. They explore feasibility assessments, protocol, country, and site-specific considerations. Kasia highlights how standard of care impacts patient enrollment, country and site selection, and overall trial efficiency. This episode is a must listen for anyone involved in planning or conducting international clinical trials.


    Follow Maya Zlatanova: https://www.linkedin.com/in/mayazlatanova/

    Follow Kasia Harris: https://www.linkedin.com/in/kasia-harris-md-16316b44/


    • (00:00) - Introduction and Background
    • (03:06) - Feasibility Assessment
    • (06:07) - Importance of Understanding the Local Standard of Care
    • (10:40) - Impact of Standard of Care on Patient Enrollment
    • (25:28) - Challenges of Assessing the Standard of Care
    • (27:09) - Standard of Care in Selecting Comparators and Budget Implications
    Show More Show Less
activate_samplebutton_t1

What listeners say about How Access to Treatments Impacts Trials: From Protocol Development, to Country and Site Selection with Kasia Harris

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.